BAIRD MEDICAL INVESTMENT HOLDINGS LIMITED

NASDAQ: BDMD (Baird Medical Investment Holdin)

Last update: 26 Dec, 2024, 12:23AM

1.77

-0.17 (-8.98%)

Previous Close 1.94
Open 2.05
Volume 65,019
Avg. Volume (3M) 66,125
Market Cap 63,177,852
Price / Earnings (TTM) 5.05
Price / Sales 1.13
Price / Book 0.960
52 Weeks Range
1.42 (-19%) — 13.52 (665%)
Profit Margin 37.96%
Operating Margin (TTM) 38.74%
Diluted EPS (TTM) 0.350
Quarterly Revenue Growth (YOY) 13.80%
Quarterly Earnings Growth (YOY) 85.80%
Total Debt/Equity (MRQ) 39.53%
Current Ratio (MRQ) 2.10
Operating Cash Flow (TTM) -5.62 M

Market Trend

Short Term Medium Term
Industry Medical Devices (US) Mixed Mixed
Medical Devices (Global) Mixed Mixed
Stock Baird Medical Investment Holdin - -

AIStockmoo Score

1.5
Analyst Consensus 0.0
Insider Activity NA
Price Volatility 0.5
Technical Moving Averages 3.5
Technical Oscillators 2.0
Average 1.50

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
BDMD 63 M - 5.05 0.960
CBLL 925 M - - -
DHAI 84 M - - 3.03
MDAI 62 M - - -
ADGM 24 M - - 0.180
QTI 9 M - - -

Baird Medical Investment Holdings Ltd is one of the microwave ablation medical device developers and providers in the PRC for minimally invasive treatment of tumors. Its proprietary medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer and breast lumps. Microwave ablation is a minimally invasive treatment technique that denaturalizes and coagulates the protein of tumor cells with extreme heat generated by microwave energy. Microwave ablation treatments have been applied to benign and malignant tumors, and the company believes the products are safer, minimally invasive and easier to operate with faster recovery periods and lower complication rates for patients, as compared to traditional treatment methods.

Sector Healthcare
Industry Medical Devices
% Held by Insiders 22.16%
% Held by Institutions 0.99%

Ownership

Name Date Shares Held
Dryden Capital, Llc 30 Jun 2024 638,277

No data within this time range.

No data within this time range.

Date Type Details
30 Dec 2024 Announcement Baird Medical Showcases Innovations in Endocrine Care at 2024 Southern Yue Forum
23 Dec 2024 Announcement Baird-Sponsored Microwave Ablation Training Enhances Thyroid Treatment
17 Dec 2024 Announcement Baird Medical Sponsored and Participated in 2024 Guangdong Thyroid Surgery Committee Annual Meeting
16 Dec 2024 Announcement Baird-Sponsored Microwave Ablation Training Advances Innovation in Thyroid Care
10 Dec 2024 Announcement Baird Medical Charts 2025 Strategic Vision Following Milestone Year
25 Nov 2024 Announcement Baird Medical Sponsored and Showcased Microwave Ablation (MWA) Technology at the 7th Thyroid Disease Forum in China
11 Nov 2024 Announcement Baird Medical Showcased Microwave Ablation Technology at Massachusetts Society of Otolaryngology Event
04 Nov 2024 Announcement Baird Medical's Advanced Microwave Ablation Solutions Captivate Attendees at the 2024 ATA Meeting
28 Oct 2024 Announcement Baird Medical Advances Global Academic Collaboration in Thyroid Health
24 Oct 2024 Announcement Baird Medical Proudly Invited to Showcase Microwave Ablation Technology at the ACS Clinical Congress
14 Oct 2024 Announcement Baird Medical to Participate in the American Thyroid Association (ATA) Annual Meeting
11 Oct 2024 Announcement Baird Medical Announces Preliminary Financial Results for the Six Months Ended June 30, 2024
09 Oct 2024 Announcement Baird Medical Lists in the U.S. on the Nasdaq Exchange
08 Oct 2024 Announcement Baird Medical to Participate in Roth's 3rd Annual Healthcare Opportunities Conference
Show more

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria